Bain Capital-backed Emcure Pharmaceuticals is set to launch its Initial Public Offering (IPO) on July 3. The initial share sale will conclude on July 5 and the bidding for anchor investors will open for a day on July 2, according to the Red Herring Prospectus (RHP).